235 related articles for article (PubMed ID: 29142180)
21. Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody.
Murai A; Shinojima N; Ikuta G; Ozono K; Ueda Y; Mabe H; Nakamura K; Iwata N; Fujisawa H; Nagamatsu F; Komatsu N; Uekawa K; Nishikawa S; Nakamura K; Mikami Y; Suzuki A; Sugimura Y; Mukasa A
Endocr J; 2023 Jul; 70(7):703-709. PubMed ID: 37045780
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition.
Urai S; Iguchi G; Kanie K; Bando H; Yamamoto M; Oi Y; Kashitani Y; Iida K; Kanzawa M; Fukuoka H; Takahashi M; Shintani Y; Ogawa W; Takahashi Y
Eur J Endocrinol; 2024 Jan; 190(1):K1-K7. PubMed ID: 38146732
[TBL] [Abstract][Full Text] [Related]
23. Acute visual loss after ipilimumab treatment for metastatic melanoma.
Wilson MA; Guld K; Galetta S; Walsh RD; Kharlip J; Tamhankar M; McGettigan S; Schuchter LM; Fecher LA
J Immunother Cancer; 2016; 4():66. PubMed ID: 27777775
[TBL] [Abstract][Full Text] [Related]
24. [Hypophysitis : Types and differential diagnosis].
Saeger W
Pathologe; 2016 May; 37(3):230-7. PubMed ID: 27103256
[TBL] [Abstract][Full Text] [Related]
25. The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature.
Urai S; Tomofuji S; Bando H; Kanzawa M; Yamamoto M; Fukuoka H; Tsuda M; Iguchi G; Ogawa W
J Neuroendocrinol; 2024 Jun; 36(6):e13395. PubMed ID: 38631695
[TBL] [Abstract][Full Text] [Related]
26. A case of isolated hypothalamitis with a literature review and a comparison with autoimmune hypophysitis.
Niri T; Horie I; Kawahara H; Ando T; Fukuhara N; Nishioka H; Inoshita N; Fujisawa H; Suzuki A; Sugimura Y; Abiru N; Kawakami A
Endocr J; 2021 Jan; 68(1):119-127. PubMed ID: 32963149
[TBL] [Abstract][Full Text] [Related]
27. Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature.
Uccella S; Amaglio C; Brouland JP; Bianconi E; Ippolito S; Messerer M; Rouiller N; Tanda ML; Sessa F; La Rosa S
Virchows Arch; 2019 Sep; 475(3):373-381. PubMed ID: 30911814
[TBL] [Abstract][Full Text] [Related]
28. Ipilimumab-induced hypophysitis and ileocolitis: Serial pituitary MRI findings.
Singh D; Hsu CC; Kwan GN; Bhuta S
Neurol India; 2017; 65(1):165-166. PubMed ID: 28084260
[No Abstract] [Full Text] [Related]
29. Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities.
Tahir SA; Gao J; Miura Y; Blando J; Tidwell RSS; Zhao H; Subudhi SK; Tawbi H; Keung E; Wargo J; Allison JP; Sharma P
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22246-22251. PubMed ID: 31611368
[TBL] [Abstract][Full Text] [Related]
30. Cancer immunotherapy-associated hypophysitis.
Solinas C; Porcu M; De Silva P; Musi M; Aspeslagh S; Scartozzi M; Willard-Gallo K; Mariotti S; Saba L
Semin Oncol; 2018 Jun; 45(3):181-186. PubMed ID: 30352754
[TBL] [Abstract][Full Text] [Related]
31. Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.
Takahashi Y; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Nishimura H; Kimura H; Suzuki M; Konno S; Shimizu A; Matsuno Y; Okamoto M; Motegi H; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Miyoshi H; Atsumi T
Pituitary; 2022 Apr; 25(2):321-327. PubMed ID: 35088194
[TBL] [Abstract][Full Text] [Related]
32. Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy.
Mekki A; Dercle L; Lichtenstein P; Nasser G; Marabelle A; Champiat S; Chouzenoux E; Balleyguier C; Ammari S
Eur J Cancer; 2019 Sep; 119():44-56. PubMed ID: 31415986
[TBL] [Abstract][Full Text] [Related]
33. Hypophysitis: a single-center case series.
Imber BS; Lee HS; Kunwar S; Blevins LS; Aghi MK
Pituitary; 2015 Oct; 18(5):630-41. PubMed ID: 25534888
[TBL] [Abstract][Full Text] [Related]
34. Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis.
Chodakiewitz Y; Brown S; Boxerman JL; Brody JM; Rogg JM
Clin Neurol Neurosurg; 2014 Oct; 125():125-30. PubMed ID: 25127260
[TBL] [Abstract][Full Text] [Related]
35. Lymphocytic hypophysitis in the elderly.
Sellayah R; Gonzales M; Fourlanos S; King J
J Clin Neurosci; 2015 Nov; 22(11):1842-3. PubMed ID: 26094558
[TBL] [Abstract][Full Text] [Related]
36. The Mayo Clinic Experience With the Neurological Complications of the CTLA-4 Inhibitor Ipilimumab.
Ruff MW; Mauermann ML
Neurologist; 2018 May; 23(3):98-99. PubMed ID: 29722744
[TBL] [Abstract][Full Text] [Related]
37. Pituitary enlargement following ipilimumab without long term endocrine dysfunction.
Nogueira E; Menon A; Dede A; Mitra I; Brock C; Larkin J; Morganstein D
Curr Probl Cancer; 2021 Dec; 45(6):100710. PubMed ID: 33622518
[TBL] [Abstract][Full Text] [Related]
38. An Atypical Case of Lymphocytic Panhypophysitis in a Pregnant Woman.
Davies EC; Jakobiec FA; Stagner AM; Rizzo JF
J Neuroophthalmol; 2016 Sep; 36(3):313-6. PubMed ID: 27008424
[TBL] [Abstract][Full Text] [Related]
39. New causes of hypophysitis.
Yuen KCJ; Popovic V; Trainer PJ
Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101276. PubMed ID: 31078416
[TBL] [Abstract][Full Text] [Related]
40. IgG4 hypophysitis - a rare and underdiagnosed cause of pituitary gland and stalk mass-like thickening.
Murphy AN; Hannon AM; Brett FM; Agha A; Javadpour M; Looby S
Br J Neurosurg; 2020 Feb; 34(1):91-93. PubMed ID: 29291640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
